JoelR LEhrenkranzMD

Adrenal Disease, Diabetes, Pituitary Disorders & Neuroendocrinology, Thyroid

Physician

Dr. Ehrenkranz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2380 N Ferguson Ave
Ste 104
Tucson, AZ 85712
Phone+1 520-324-1010

Fax+1 520-324-0029

Atlantic Health System/Morristown Medical CenterResidency, Internal Medicine, 1982 - 1983
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1978 - 1979
NYU Grossman School of MedicineInternship, Internal Medicine, 1977 - 1978
Stanford University School of MedicineClass of 1977

PubMed

27 citations
Potential risks of excess iodine ingestion and exposure: statement by the american thyroid association public health committee.
Angela M. Leung, Anca M. Avram, Alina V. Brenner, Leonidas H. Duntas, Joel Ehrenkranz
Thyroid. 2015-02-01
602 citations
Phlorizin: a review.
Joel R. L. Ehrenkranz, Norman G. Lewis, C. Ronald Kahn, Jesse Roth
Diabetes/metabolism Research and Reviews. 2005-01-01
64 citations
Thyroid Hormone Reduces Cholesterol via a Non-LDL Receptor-Mediated Pathway
Ira J. Goldberg, Li Shin Huang, Lesley Ann Huggins, Shuiqing Yu, Prabhakara R Nagareddy
Endocrinology. 2012-09-04

Renowned Advocate for Adolescent Health Appointed Dean for Global Health, Social Justice, and Human Rights at Icahn School of Medicine at Mount SinaiOctober 8th, 2021
The Mount Sinai Hospital’s Department of Geriatrics Remains No. 1 in U.S. News & World Report Specialty Rankings for Second YearJuly 27th, 2021
Thomas J. Fuchs, DSc, Named Dean of AI and Human Health and Co-Director of the Hasso Plattner Institute for Digital Health at Mount SinaiOctober 7th, 2020
Join now to see all